Rising Prevalence of Hemophilia, Increasing Adoption of Recombinant Therapies, and Breakthroughs in Gene Therapy Propel Market Growth.Pune, March 12, 2025 (GLOBE NEWSWIRE) -- Hemophilia Market Size & ...

However, it turns out that anyone can be affected by hemophilia. Hemophilia could potentially develop in every ten-thousandth newborn. Intriguingly, women act as asymptomatic carriers, with the ...

Lackey is learning to live with a severe case of hemophilia B, a rare genetic condition that keeps blood from clotting properly. That disease required him to have surgery on his right elbow ...

“Gene therapy for hemophilia A with the use of lentiviral vector-transduced autologous HSCs resulted in stable factor VIII ...

Market Valuation Set to Surge from USD 13.23 Billion in 2024 at a CAGR of 5.69% ...

When a test determined that Walter had hemophilia, his Omaha owner joined a group seeking to raise $50,000 for a clinical trial of a gene therapy for dogs. Emily Wiley wasn’t looking to take Walter ...

Weak demand for Pfizer’s hemophilia gene therapy Beqvez has led the pharmaceutical company to “cease further development and commercialization” of the one-time treatment, a Pfizer spokesperson ...

The changes at Spark follow Roche's decision last year to halt development of a gene therapy for hemophilia A that was the ...

Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. The New York pharma is ending global development and commercialization of ...

Jammu Hemophilia Society, in collaboration with the Department of Paediatrics of Shri Maharaja Gulab Singh (SMGS) Hospital ...

Did you know that 1 in every 76 Americans is affected by a blood disorder? That means that a simple cut or routine surgery to ...

When a test determined that Walter had hemophilia, his Omaha owner joined a group seeking to raise $50,000 for a clinical trial of a gene therapy for dogs. Emily Wiley wasn’t looking to take ...